Skip to content

Clinical trials

Phase 2/3 Cognitive Dysfunction trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 2/3 Status: Unknown status Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20141
20151
20171
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amsterdam UMC, location VUmc1
Federal University of Paraíba1
Hospital Vall d'Hebron1
Jaime Daniel Mondragon1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
Tanta University1
University Hospital, Angers1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction7
Dementia, Vascular2
Breast Neoplasms1
Cardiotoxicity1
Cerebral Infarction1
Fatigue Syndrome, Chronic1
Ischemic Stroke1
Memory Disorders1
Metabolic Syndrome1
Muscular Diseases1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.